Inscription Verification, Cemetery Compliance Automation, and Grief-Sensitive Communication Prevent Costly Errors in an Industry Where Mistakes Are Permanent LOS ANGELES — A monument dealer in Pennsylvania recently caught a single-digit error in a headstone inscription: 1948 instead of 1949. On a screen the mistake appeared minor. Carved into granite, it would have become an irreversible...
Author: Arthur (Arthur )
MountChief Launches as the First Dedicated Management Software for Taxidermy Shops
Self-Service Customer Portal and Automated Updates Eliminate ‘Where’s My Mount?’ Calls, Freeing Artists to Focus on Craft LOS ANGELES — In taxidermy shops across America, one question dominates daily life. It arrives by phone, text, email, and unannounced weekend visitors: “Where’s my mount?” Customers drop off a deer, elk, bass, or duck and wait months...
StitchDesk Launches as the First Operating System Built Specifically for the Upholstery Industry
Revolutionary AI-Powered Platform Transforms Shop Management, Delivering Precise Fabric Estimates and Streamlined Workflows LOS ANGELES — The $6 billion U.S. upholstery industry relies on tens of thousands of skilled craftspeople who reupholster worn furniture, craft custom pieces, and restore marine interiors exposed to harsh sun and saltwater. This work demands precision, artistry, and expertise, yet...
Chintai: Leading the Tokenization of Real-World Assets, Reshaping the New Landscape of Global Finance
Setting Sail from Singapore, Bound for the World In 2019, a blockchain infrastructure provider with a dream of financial innovation—Chintai—was officially established in Singapore. In just a few years, it has evolved into a compliant digital asset trading platform regulated and licensed by the Monetary Authority of Singapore (MAS). Holding two licenses for tokenized securities,...
In ‘Rooster,’ Steve Carell leads a gentle comedy about a father-daughter relationship
HBO’s new comedy, created by Bill Lawrence and Matt Tarses, stars Steve Carell as a concerned father whose college professor daughter is reeling after a breakup.
Tech for All, Health Without Borders-TYILLO’s Global Strategy Officially Launched
In recent years, the global health industry has accelerated its high-quality development, and consumer demand for safe, efficient, and cost-effective scientific nutrition products continues to rise. As an international health technology brand driven by technological innovation, TYILLO has always upheld the brand mission of “Tech for All, Health Without Borders” and built a full-chain independent...
Tech for All, Health Without Borders-TYILLO’s Global Strategy Officially Launched
In recent years, the global health industry has accelerated its high-quality development, and consumer demand for safe, efficient, and cost-effective scientific nutrition products continues to rise. As an international health technology brand driven by technological innovation, TYILLO has always upheld the brand mission of “Tech for All, Health Without Borders” and built a full-chain independent...
Bide Pharmatech’s 2025 Net Profit Grows by 29.61% as Overseas Market Continues to Expand
On February 28, Bide Pharmatech (688073.SH) released its 2025 preliminary earnings estimate, delivering an outstanding report card with strong growth in both revenue and net profit. The report shows that the company achieved a total annual operating revenue of 1.3238 billion yuan (RMB 1,323,810,700) in 2025, a year-on-year increase of 20.13%; the net profit attributable...
Bide Pharmatech’s 2025 Net Profit Grows by 29.61% as Overseas Market Continues to Expand
On February 28, Bide Pharmatech (688073.SH) released its 2025 preliminary earnings estimate, delivering an outstanding report card with strong growth in both revenue and net profit. The report shows that the company achieved a total annual operating revenue of 1.3238 billion yuan (RMB 1,323,810,700) in 2025, a year-on-year increase of 20.13%; the net profit attributable...
Bide Pharmatech’s 2025 Net Profit Grows by 29.61% as Overseas Market Continues to Expand
On February 28, Bide Pharmatech (688073.SH) released its 2025 preliminary earnings estimate, delivering an outstanding report card with strong growth in both revenue and net profit. The report shows that the company achieved a total annual operating revenue of 1.3238 billion yuan (RMB 1,323,810,700) in 2025, a year-on-year increase of 20.13%; the net profit attributable...



